Mechanism whereby different anti-oxidants and lipoxigenase pathway inhibitors suppress IL2 synthesis.
Dornand
J
J
CNRS, Laboratoire de Biochímie des Membranes, Ecole de Chimie, Montpellier, France.
Gerber
M
M
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002449:Cell Aggregation / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007376:Interleukin-2 / Q000096:biosynthesis*; D016859:Lipoxygenase Inhibitors; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000975:Antioxidants; D007376:Interleukin-2; D016859:Lipoxygenase Inhibitors; D003208:Concanavalin A; D000001:Calcimycin; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium